Buscas alternativas:
decrease processes » disease processes (Expandir a busca), decay processes (Expandir a busca), increase process (Expandir a busca)
decrease decrease » decrease release (Expandir a busca), disease decreases (Expandir a busca), decreases disease (Expandir a busca)
decrease primary » decrease urinary (Expandir a busca), increased primary (Expandir a busca), disease primary (Expandir a busca)
primary efficacy » preliminary efficacy (Expandir a busca), optimal efficacy (Expandir a busca), proxy efficacy (Expandir a busca)
decrease and » decreases and (Expandir a busca), decrease in (Expandir a busca), decrease of (Expandir a busca)
and decrease » and decreases (Expandir a busca), and decreased (Expandir a busca), and increase (Expandir a busca)
decrease processes » disease processes (Expandir a busca), decay processes (Expandir a busca), increase process (Expandir a busca)
decrease decrease » decrease release (Expandir a busca), disease decreases (Expandir a busca), decreases disease (Expandir a busca)
decrease primary » decrease urinary (Expandir a busca), increased primary (Expandir a busca), disease primary (Expandir a busca)
primary efficacy » preliminary efficacy (Expandir a busca), optimal efficacy (Expandir a busca), proxy efficacy (Expandir a busca)
decrease and » decreases and (Expandir a busca), decrease in (Expandir a busca), decrease of (Expandir a busca)
and decrease » and decreases (Expandir a busca), and decreased (Expandir a busca), and increase (Expandir a busca)
1
2
3
4
5
6
“... cellular and molecular processes leading to scar formation and remodelling had already occurred, or were...”
Acessar documento
Acessar documento
7
8
“... distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https...”
Acessar documento
Acessar documento
Artigo
9
“... expression in in vitro cultured S. mansoni primary sporocysts and/or their potential involvement...”
Acessar documento
Acessar documento
Tese
10
11
12
13
14
15
“... for Systhematic Reviews and Meta-analyses (Prisma), com protocolo registrado no PROSPERO sob o n° CRD42022321200...”
Acessar documento
Acessar documento
Dissertação
16
“.... However, it is still questioned about the real effect and also the dosimetry more effective for this...”
Acessar documento
Acessar documento
Dissertação
17
“... a significant IFNR1 (p=0.0391) and IRF7 (p=0.05) decrease in patients who did not achieve lesion regression when...”
Acessar documento
Acessar documento
Tese
18
19
20